Topolewski, P.; Łaski, D.; Łukasiewicz, M.; Domagała, P.; de Wilde, R.F.; Polak, W.G.
Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review. Cancers 2024, 16, 3862.
https://doi.org/10.3390/cancers16223862
AMA Style
Topolewski P, Łaski D, Łukasiewicz M, Domagała P, de Wilde RF, Polak WG.
Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review. Cancers. 2024; 16(22):3862.
https://doi.org/10.3390/cancers16223862
Chicago/Turabian Style
Topolewski, Paweł, Dariusz Łaski, Martyna Łukasiewicz, Piotr Domagała, Roeland F. de Wilde, and Wojciech G. Polak.
2024. "Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review" Cancers 16, no. 22: 3862.
https://doi.org/10.3390/cancers16223862
APA Style
Topolewski, P., Łaski, D., Łukasiewicz, M., Domagała, P., de Wilde, R. F., & Polak, W. G.
(2024). Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review. Cancers, 16(22), 3862.
https://doi.org/10.3390/cancers16223862
